Literature DB >> 11727275

Statistical significance versus clinical relevance in cardiovascular medicine.

R Willenheimer1.   

Abstract

Evidence-based medicine is the foundation of everyday clinical practices and large clinical trials investigating the effects of various interventions on morbidity and survival and generally provide the most robust evidence. Cardiovascular medicine is considered one of the most evidence-based disciplines of medicine. However, there are a number of limitations to the general applicability of clinical trial results in cardiovascular medicine. Although generally useful to the clinician, clinical trials have often been suboptimally designed from 1 or several points of view. As a consequence of flaws in the design and the execution of the trials, statistical significance is quite often not equal to clinical relevance. This article outlines some of the shortcomings of designing and carrying out clinical trials, as well as inadequacies concerning the publication, interpretation, and implementation of the trial results. Evidence-based medicine is obviously not always as solid as one might think. Copyright 2001 by W.B. Saunders Company

Mesh:

Substances:

Year:  2001        PMID: 11727275     DOI: 10.1053/pcad.2001.29144

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  3 in total

1.  Clinicians' Guide to Statistics for Medical Practice and Research: Part II.

Authors:  Marie A Krousel-Wood; Richard B Chambers; Paul Muntner
Journal:  Ochsner J       Date:  2007

2.  Aspirin use is associated with an improved long-term survival in an unselected population presenting with unstable angina.

Authors:  Louai Razzouk; Verghese Mathew; Ryan J Lennon; Ashish Aneja; Joshua I Mozes; Heather J Wiste; Paul Muntner; James H Chesebro; Michael E Farkouh
Journal:  Clin Cardiol       Date:  2010-09       Impact factor: 2.882

3.  Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmö preventive project.

Authors:  G Tasevska-Dinevska; L M A Kennedy; P M Nilsson; R Willenheimer
Journal:  Eur J Epidemiol       Date:  2009-03-08       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.